drugset / Trial / NCT06241222

Origin of the Neonatal Gut Microbiota and Probiotic Intervention

NCT06241222

RandomizedSingle-groupQuadruple-blindHealth-services research

Summary

This study aim to evaluate the composition and origin of the neonatal gut microbiota after birth and Probiotic intervention. Samples were obtained from a total of 30 pregnant individuals and their offspring, divided into control group and porbiotics group. Postpartum human milk and infant fecal specimens were collected for a period of 6 months. The samples were analyzed using 16S rRNA amplicon sequencing of the V3-V4 region to evaluate the microbial composition. The Shannon index, Simpson index and nonmetric multidimensional scaling were used to evaluate the diversity of the microbiota, while the co-occurrence network and LEfSe were used to evaluate the characteristics of the microbiota of pregnancies and their infants in each groups.

Timeline

Start
2018-01-01
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifidobacterium longum Other / unclassified 5e+06 cells Oral
Subject Lactobacillus delbrueckii bulgaricus Unknown 500000 cells Oral
Subject Streptococcus thermophilus Unknown 500000 cells Oral

Indications

No indication recorded.